The contribution of molecular markers to the prediction of response in the treatment of breast cancer: A review of the literature on HER-2, p53 and BCL-2-Reference-Cited by-同舟云学术

The contribution of molecular markers to the prediction of response in the treatment of breast cancer: A review of the literature on HER-2, p53 and BCL-2

Published:2000-06 Issue:6 Volume:11 Page:647-663
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Hamilton A.,Piccart M.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/11/6/647/19478343/11-6-647.pdf

Reference68 articles.

1. Polychemo-therapy for early breast cancer: An overview of the randomised trials;Lancet,1998

2. Hormonal therapy and chemotherapy;Honig,1996

3. Tamoxifen for early breast cancer: An overview of the randomised trials;Lancet,1998

4. Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease;Cobleigh;J Clin Oncol,1999

5. Overall survival advanvtage to simultaneous chemotherapy plus the humanized anti-HER2 monoclonal antibody herceptin in HER2-over-expressing metastatic breast cancer;Norton;Proc ASCO,1999

Cited by 140 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is Ki-67 Really Useful as a Predictor for Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer?;Indian Journal of Surgical Oncology;2023-09-29

2. Role of transcriptional and posttranscriptional regulation of sphingolipid genes in molecular heterogeneity of breast cancer;Transcription and Translation in Health and Disease;2023

3. Role of p53 and Her2/Neu as a prognostic biomarker in breast carcinoma;Medical Journal of Dr. D.Y. Patil Vidyapeeth;2022

4. DNA replication and sister chromatid cohesion 1 promotes breast carcinoma progression by modulating the Wnt/β-catenin signaling and p53 protein;Journal of Biosciences;2020-10-13

5. Ki-67 labeling index as a predictor of response to neoadjuvant chemotherapy in breast cancer;Japanese Journal of Clinical Oncology;2019-02-08